Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Banthien, I. Chrobak, M. Konigshoff, K. Kitowska, W. Seeger, O. Eickelberg (Giessen, Germany). Four-and-a-half-LIM-domain (FHL)-2 acts as an enhancer of TGF-beta signaling in pulmonary fibrosis. Eur Respir J 2007; 30: Suppl. 51, 1848

Member's Comments

No comment yet.

Related content which might interest you: 6-aminonicotinamide ameliorates pulmonary fibrosis by suppressing the TGF-beta1 activated Smad signalling pathway Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 Wnt signalling and parenchymal fibrosis Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 Non-canonical WNT signaling is mediated by extracellular vesicles in pulmonary fibrosis Source: ERS Lung Science Conference 2016 Year: 2016 TRIM33 prevents pulmonary fibrosis by impairing TGF-ß1 signalling Source: Eur Respir J, 55 (6) 1901346; 10.1183/13993003.01346-2019 Year: 2020 Dickkopf proteins influence lung epithelial cell proliferation in idiopathic pulmonary fibrosis Source: Eur Respir J 2011; 37: 79-87 Year: 2011 Wnt and TGF-beta signaling in lung development Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 17(R)-resolvinD1 mediates a pathway involving the transcription factor c-Fos to reduce bleomycin-induced pulmonary fibrosis in mice. Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias Year: 2018 HIF pathway activation is a core regulator of collagen structure-function in lung fibrosis Source: Virtual Congress 2020 – Lung epithelial development and repair in three-dimensions Year: 2020 The matrix-fibroblast interplay contributes to HIF-1 alpha pathway activation: a possible therapeutic target in idiopathic pulmonary fibrosis (IPF) Source: Virtual Congress 2020 – Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro Year: 2020 Expression of Smad proteins during myofibroblast differentiation in pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 267s Year: 2005 Pharmacological activation of Nur77 enhances BMP signalling and inhibits vascular remodelling in pulmonary arterial hypertension Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Increased pulmonary Wnt signaling in patients with sarcoidosis Source: Annual Congress 2007 - Interstitial lung disease: diagnostic and therapeutic novelties Year: 2007 Imbalanced expression of the type I TGF-beta receptors ALK-1 in pulmonary fibrosis Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis Year: 2009 Altered expression of the Smad signalling pathway: implications for COPD pathogenesis Source: Eur Respir J 2006; 28: 533-541 Year: 2006 Chaotic activation of developmental signalling pathways drives idiopathic pulmonary fibrosis Source: Eur Respir Rev, 29 (158) 190140; 10.1183/16000617.0140-2019 Year: 2020 LSC Abstract – Non-canonical WNT signaling is mediated by extracellular vesicles in pulmonary fibrosis Source: International Congress 2016 – New genomic targets in pulmonary disease Year: 2016 Role of leukotriene receptor antagonist on TGF-β1 and Smad signalling in bleomycin induced pulmonary fibrosis Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009 The lung epithelium is a prominent source of Wnt ligands and inhibitors in idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon Year: 2008